New imaging technique for anal cancer screening
Probe-Based Light Sheet Microscopy (pLSM) for Screening of Anal Cancer
This study is testing a new imaging technique to help doctors better spot early signs of anal cancer, making it easier for them to diagnose and treat patients who have high-grade lesions that could lead to cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11036694 on NIH RePORTER |
What this research studies
This research investigates a novel, non-invasive imaging method called probe-based light sheet microscopy (pLSM) to improve the screening process for anal cancer. The study aims to enhance diagnostic accuracy for high-grade squamous intraepithelial lesions (HSIL), which are precursors to anal cancer, by utilizing advanced imaging technology. By optimizing this technique for clinical applications, the researchers hope to provide clearer visualizations of tissue samples, making it easier for pathologists to diagnose anal cancer accurately. The project builds on previous findings that suggest early treatment of HSIL can significantly reduce the risk of developing anal cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for anal cancer, particularly those with a history of HSIL or other related conditions.
Not a fit: Patients who do not have risk factors for anal cancer or those who have already been diagnosed and treated may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and efficient screening for anal cancer, ultimately reducing mortality rates associated with the disease.
How similar studies have performed: Previous studies using advanced imaging techniques have shown promise in improving diagnostic accuracy in other cancer types, suggesting potential success for this novel approach.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Kang, Dongkyun — University of Arizona
- Study coordinator: Kang, Dongkyun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.